Cargando…

Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study

Aims: Although several antihypertensive agents reduced the carotid intima-media thickness (IMT), it remains unclear whether those agents affect the interadventitial diameter (IAD). We aimed to examine whether cilnidipine, an L/N-type calcium channel blocker, reduced the common carotid IMT or IAD in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nezu, Tomohisa, Hosomi, Naohisa, Aoki, Shiro, Suzuki, Noriyuki, Teshima, Tsukasa, Sugii, Hitoshi, Nagahama, Shinobu, Kurose, Yoshiki, Maruyama, Hirofumi, Matsumoto, Masayasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005225/ https://www.ncbi.nlm.nih.gov/pubmed/29225324 http://dx.doi.org/10.5551/jat.42101

Ejemplares similares

Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey
por: Kario, Kazuomi, et al.
Publicado: (2021)

Steroid-responsive Nivolumab-induced Involuntary Movement with Anti-thyroid Antibodies
por: Maetani, Yuta, et al.
Publicado: (2019)

Usefulness of Carotid Ultrasonography for Risk Stratification of Cerebral and Cardiovascular Disease
por: Nezu, Tomohisa, et al.
Publicado: (2020)

A case of seronegative longitudinally extensive transverse myelitis with possible neuro sweet disease
por: Toko, Megumi, et al.
Publicado: (2020)

Telomere G-tail Length is a Promising Biomarker Related to White Matter Lesions and Endothelial Dysfunction in Patients With Cardiovascular Risk: A Cross-sectional Study()
por: Nezu, Tomohisa, et al.
Publicado: (2015)

Alpha-2-macroglobulin as a Promising Biological Marker of Endothelial Function
por: Shimomura, Ryo, et al.
Publicado: (2018)

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event
por: Hosomi, Naohisa, et al.
Publicado: (2018)

Various meteorological conditions exhibit both immediate and delayed influences on the risk of stroke events: The HEWS–stroke study
por: Mukai, Tomoya, et al.
Publicado: (2017)

Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study
por: Nezu, Tomohisa, et al.
Publicado: (2020)

Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS
por: Hosomi, Naohisa, et al.
Publicado: (2020)

Long-Term Effect of Pravastatin on Carotid Intima–Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke)
por: Koga, Masatoshi, et al.
Publicado: (2018)

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study
por: Wada, Shinichi, et al.
Publicado: (2018)

Giant Cell Arteritis with Internal Carotid Artery Occlusion in the Absence of Typical Clinical Features
por: Kikumoto, Mai, et al.
Publicado: (2020)

Increased Serum Alkaline Phosphatase and Functional Outcome in Patients with Acute Ischemic Stroke Presenting a Low Ankle–Brachial Index
por: Naito, Hiroyuki, et al.
Publicado: (2022)

The Multidisciplinary Swallowing Team Approach Decreases Pneumonia Onset in Acute Stroke Patients
por: Aoki, Shiro, et al.
Publicado: (2016)

Association between Carotid Wall Shear Stress-Based Vascular Vector Flow Mapping and Cerebral Small Vessel Disease
por: Kamimura, Teppei, et al.
Publicado: (2023)

Increased blood pressure variability during the subacute phase of ischemic stroke is associated with poor functional outcomes at 3 months
por: Naito, Hiroyuki, et al.
Publicado: (2020)

Preparation and evaluation of cilnidipine microemulsion
por: Tandel, Hemal, et al.
Publicado: (2012)

Cilnidipine induced ankle edema
por: Annil, Vishal R., et al.
Publicado: (2014)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
por: Maria, Steffi A., et al.
Publicado: (2023)

Serum IgG titers against periodontal pathogens are associated with cerebral hemorrhage growth and 3-month outcome
por: Nakamori, Masahiro, et al.
Publicado: (2020)

Serum IgG titers to periodontal pathogens predict 3-month outcome in ischemic stroke patients
por: Aoki, Shiro, et al.
Publicado: (2020)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
por: Gopinath, Sameera, et al.
Publicado: (2019)

Association between periodontal disease due to Campylobacter rectus and cerebral microbleeds in acute stroke patients
por: Shiga, Yuji, et al.
Publicado: (2020)

Predictors of Stroke Outcome Extracted from Multivariate Linear Discriminant Analysis or Neural Network Analysis
por: Nezu, Tomohisa, et al.
Publicado: (2022)

Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats
por: Aritomi, Shizuka, et al.
Publicado: (2015)

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
por: Hosomi, Naohisa, et al.
Publicado: (2015)

Excellent Tolerance to Cilnidipine in Hypertensives with Amlodipine - Induced Edema
por: Shetty, Ranjan, et al.
Publicado: (2013)

Changes over Time in Intracranial Air in Patients with Cerebral Air Embolism: Radiological Study in Two Cases
por: Kaichi, Yoko, et al.
Publicado: (2015)

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials
por: Chakraborty, Rabindra Nath, et al.
Publicado: (2021)

Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies
por: Srivathsan, Mayakalyani, et al.
Publicado: (2022)

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension
por: Kumar, Prakash, et al.
Publicado: (2016)

Effects of the N/L‐Type Calcium Channel Blocker Cilnidipine on Nephropathy and Uric Acid Metabolism in Hypertensive Patients With Chronic Kidney Disease (J‐CIRCLE Study)
por: Uchida, Shunya, et al.
Publicado: (2014)

Immediate effect of passive and active stretching on hamstrings flexibility: a single-blinded randomized control trial
por: Nishikawa, Yuichi, et al.
Publicado: (2015)

Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus
por: Mori, Yutaka, et al.
Publicado: (2014)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2014)

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension
por: Das, Arijit, et al.
Publicado: (2016)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ec1nq3vlb9ms21b3js84qbvao5